Management of Hepatitis C in the Primary Care Setting

On-Demand Webinar   |   Oct. 12, 2017




CME CREDITS: 0.0 (no longer eligible)

CME Participation Waiver *
By registering for the webinar, you are confirming that you agree to the waiver available at the bottom of this page.


Medical Director, Center for Key Populations, Community Health Center, Inc., Middletown, CT


Dr. Marwan Haddad is currently the Medical Director of the Center for Key Populations at Community Health Center, Inc. (CHC), the first center of its kind focused on engaging populations who traditionally experience barriers to comprehensive and respectful care. The Center recognizes five key groups who carry the highest burden of and risk for HIV infection and brings together under one roof healthcare and advocacy for the LGBTQ (Lesbian, Gay, Bisexual, Transgender, and Questioning) community, people who use drugs, the homeless and those experiencing housing instability, the recently incarcerated, and sex workers. Dr. Haddad joined CHC, the largest federally qualified health center in New England, in July 2006.

He received his Bachelor of Arts degree from Harvard College and his medical degree from McGill University. He completed his family medicine residency at University of Toronto and obtained his Masters in Public Health from Johns Hopkins University. He is board certified in Family Medicine. He is certified by the American Academy of HIV Medicine as an HIV specialist. He was also the recipient of the 2011 Primary Care Leadership Award presented by the Connecticut Center for Primary Care. Dr. Haddad is an Assistant Clinical Professor of Family Medicine at Quinnipiac University.

Since January 2012, Dr. Haddad has led the CHC Project ECHO HIV, Hepatitis C, and Buprenorphine programs which expand the integration of these programs not only within CHC but nationwide. This model of care utilizes didactic and case-based learning via weekly video conferences with medical providers, offering ongoing support, consultation and guidance to aid in delivering care to the HIV, Hepatitis C, and opioid dependent populations. Moreover, Dr. Haddad has taught and lectured at state and national conferences on HIV, HCV, buprenorphine and integrated care. He has published research on the integration of buprenorphine in community health centers examining both substance abuse as well as primary care outcomes.



The Centers for Disease Control and Prevention (CDC) estimate that 3.2 million people in the United States are living with chronic hepatitis C infection, and most don´t feel ill or know they are infected. There are approximately 17,000 new hepatitis C cases each year in the U.S., many of which go unreported. Although it is usually asymptomatic, new screening recommendations have enabled Hepatitis C increased recognition by primary care providers. Evolving treatment recommendations are making this a treatable infection for many patients. In this lecture, we will discuss advances in screening, diagnosis and treatment of Hepatitis C in the primary care setting.


This lecture will be conducted as a one-hour live webinar. Registration is free. Participants will submit a survey at the end of the session to claim CME credit.


  • J. Nwando Olayiwola, MD, MPH, FAAFP

  • Anna Potapov, MD, MPH, MBA

  • Marc E. Walker, MD, MBA

  • Pooja Mittal, DO



By the end of the event, participants should:

  1. Understand current guidelines for Hepatitis C screening in the primary care setting

  2. Understand the latest approaches to management of Hepatitis C in the primary care setting

  3. Learn strategies to engage a multi-disciplinary team to care for patients with Hepatitis C